Yongquan Chi

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial.

Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial.

Journal: BMJ open
Published: February 23, 2026

Reply: Key advance in noninvasive fibrosis assessment: Evidence from China.

Reply: Key advance in noninvasive fibrosis assessment: Evidence from China.

Journal: Hepatology (Baltimore, Md.)
Published: September 02, 2025

Reply: Can plasma FSTL-1 levels serve as a reliable biomarker for advanced fibrosis?

Reply: Can plasma FSTL-1 levels serve as a reliable biomarker for advanced fibrosis?

Journal: Hepatology (Baltimore, Md.)
Published: December 02, 2024

Novel system for organ preservation in liver transplantation: Feed macrophages with ceria nanoparticles.

Novel system for organ preservation in liver transplantation: Feed macrophages with ceria nanoparticles.

Journal: Chinese medical journal
Published: November 12, 2024

Macrophage Nogo-B Drives Liver Fibrosis.

Macrophage Nogo-B Drives Liver Fibrosis.

Journal: Cellular and molecular gastroenterology and hepatology
Published: October 22, 2024

Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.

Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.

Journal: MedComm
Published: September 24, 2024

Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis.

Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis.

Journal: Hepatology (Baltimore, Md.)
Published: August 27, 2024

XBP1 Facilitating NF-κB-p65 Nuclear Translocation Promotes Macrophage-Originated Sterile Inflammation Via Regulating MT2 Transcription in the Ischemia/Reperfusion Liver.

XBP1 Facilitating NF-κB-p65 Nuclear Translocation Promotes Macrophage-Originated Sterile Inflammation Via Regulating MT2 Transcription in the Ischemia/Reperfusion Liver.

Journal: Cellular and molecular gastroenterology and hepatology
Published: March 06, 2024
Showing 1-8 of 8

Last Updated: 09/26/2026